Prenetics Global Ltd·4

May 28, 10:32 AM ET

Cheng Yin Pan 4

Research Summary

AI-generated summary

Updated

Prenetics (PRE) Director Cheng Yin Pan Receives 6,406 RSUs

What Happened

  • Cheng Yin Pan, a director of Prenetics Global Ltd (PRE), was awarded 6,406 Restricted Stock Units (RSUs) on 2026-05-26. The RSUs are derivative awards (grant price $0.00) and have no immediate cash value reported ($0).
  • The RSUs were granted under the Issuer’s 2022 Share Incentive Plan and will convert to one Class A ordinary share each if and when vested.

Key Details

  • Transaction date: 2026-05-26; filing date: 2026-05-28 (filed within the standard 2-business-day Form 4 window).
  • Award: 6,406 RSUs @ $0.00 (derivative grant); reported value $0 at grant.
  • Vesting schedule: all 6,406 RSUs vest on May 17, 2027, subject to continued service.
  • Settlement: Vested RSUs held by M13 Capital Management Holdings Limited (a BVI entity wholly owned by Cheng Yin Pan) are not automatically settled; delivery of shares occurs at Cheng’s election per the company’s insider trading policy.
  • Shares owned after transaction: not specified in the filing.
  • Footnotes: RSUs represent contingent rights to receive Class A ordinary shares upon vesting; M13 is wholly owned by Cheng Yin Pan.

Context

  • RSU grants are awards that become shares only if vesting conditions are met; they do not reflect an immediate cash purchase or sale. This is a routine equity grant to a director rather than an open-market purchase or sale. Settlement timing and any resulting share sales or tax withholding will depend on Cheng’s later election and any company policies.